new drug approvals

new drug approvals

Biotech IPOs Sizzle Amid R&D Successes

online.wsj.com
Biotechnology companies are enjoying their best run with initial public offerings in a decade, amid an upswing in new drug approvals, strong performance by some already public biotech firms and legal changes....
Biotech IPOs Sizzle Amid R&D Successes
× Just a test of the new info bar. What do you think?